To investigate whether Gal-9 is involved in PD-related neurodegeneration in vivo, we chose a classical PD model by intraperitoneal injection of MPTP (20 mg/kg body weight) for 7 days (Figure 4). The gene discussed is LGALS9; the disease is Parkinson disease.